| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/26/2004 | EP1421948A2 Use of botulinum toxins for treating sweating in humans |
| 05/26/2004 | EP1421946A1 A pharmaceutical being used for treating hiv infection, the composition and uses thereof |
| 05/26/2004 | EP1421937A1 Use of amino acids for making medicines for treating insulin-resistance |
| 05/26/2004 | EP1421539A2 Stabilized proteins with engineered disulfide bonds |
| 05/26/2004 | EP1421391A2 Sodium channel regulators and modulators |
| 05/26/2004 | EP1421388A2 Diagnosis of carcinomas |
| 05/26/2004 | EP1421384A2 Hprp4s as modifiers of the p53 pathway and methods of use |
| 05/26/2004 | EP1421222A2 Cell culture system for synthesis of infectious hepatitis c virus |
| 05/26/2004 | EP1421221A2 Methods for diagnosing and treating neoplasias using nf-at transcription factors |
| 05/26/2004 | EP1421218A2 Model of autoimmune disease and methods for identifying agents against autoimmune disease |
| 05/26/2004 | EP1421208A2 Polynucleotides encoding two novel human g-protein coupled receptors, hgprbmy28 and hgprbmy29, and splice variants thereof |
| 05/26/2004 | EP1421204A2 Iap binding peptides and assays for identifying compounds that bind iap |
| 05/26/2004 | EP1421199A2 Compositions and methods for treating neurodegenerative diseases |
| 05/26/2004 | EP1421198A2 Cell-based high-throughput screening methods |
| 05/26/2004 | EP1421192A1 Regulation of human ptpase-like protein |
| 05/26/2004 | EP1421190A2 Metabolic gene polynucleotides and polypeptides and uses thereof |
| 05/26/2004 | EP1421186A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/26/2004 | EP1421177A2 Zinc finger binding domains for cnn |
| 05/26/2004 | EP1421174A2 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 05/26/2004 | EP1421115A2 Soluble t cell receptor |
| 05/26/2004 | EP1421112A1 Novel serine protease |
| 05/26/2004 | EP1421111A2 Proteins associated with cell growth differentiation, and death |
| 05/26/2004 | EP1421110A2 Novel genetic products from ashbya gossypii, associated with the structure of the cell wall or the cytoskeleton |
| 05/26/2004 | EP1421109A2 Non-mammalian gnrh analogs and uses thereof in regulation of fertility and pregnancy |
| 05/26/2004 | EP1421108A2 Antimicrobial and anti-inflammatory peptides |
| 05/26/2004 | EP1421107A1 Peptides having antiangiogenic activity |
| 05/26/2004 | EP1421106A2 Catalysis of the cis/trans isomerisation of secondary amide peptide compounds |
| 05/26/2004 | EP1421105A1 Anti-cancer cyclopenta[g]quinazoline compounds |
| 05/26/2004 | EP1421104A2 Human zona pellucida proteins and methods of their use in diagnosing male infertility |
| 05/26/2004 | EP1421101A2 P-glycoproteins and uses thereof |
| 05/26/2004 | EP1420828A2 Lipophilic drug compositions |
| 05/26/2004 | EP1420827A1 5-cnac as oral delivery agent for parathyroid hormone fragments |
| 05/26/2004 | EP1420826A2 Combination preparations of aryl substituted propanolamine derivatives with other active ingredients and the use thereof |
| 05/26/2004 | EP1420821A2 Immunologically significant herpes simplex virus antigens and methods for using same |
| 05/26/2004 | EP1420820A2 Antigens of and antibodies to translocated molecules of microorganisms and uses thereof |
| 05/26/2004 | EP1420817A1 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments |
| 05/26/2004 | EP1420816A2 Uses of mammalian cytokine; related reagents |
| 05/26/2004 | EP1420815A2 Beta-amyloid-analogue - t-cell epitop vaccine |
| 05/26/2004 | EP1420814A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 05/26/2004 | EP1420813A1 Pregnancy-related enzyme activity |
| 05/26/2004 | EP1420812A1 Use of leptin for infant with low birth weight for prevention of obesity |
| 05/26/2004 | EP1420811A2 Method and composition for prophylaxis of diabetes |
| 05/26/2004 | EP1420810A1 Modulation of leukocyte-endothelial interactions following ischemia |
| 05/26/2004 | EP1420809A1 Use of cyclopenta[g]quinazoline derivatives for treating cancer |
| 05/26/2004 | EP1420808A1 Treatment of tuberculosis using immunomodulator compounds |
| 05/26/2004 | EP1420807A1 Platelet-derived growth factor protection of cardiac myocardium |
| 05/26/2004 | EP1420806A2 Triple polypeptide complexes |
| 05/26/2004 | EP1420800A1 Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at 4) receptor activity |
| 05/26/2004 | EP1420762A1 Residual solvant extraction method and microparticles produced thereby |
| 05/26/2004 | EP1420760A2 Aerosolized decongestants for the treatment of sinusitis |
| 05/26/2004 | EP1420748A2 Peg-modified uricase |
| 05/26/2004 | EP1420716A1 An implantable and sealable system for unidirectional delivery of therapeutic agents to targeted tissues |
| 05/26/2004 | EP1420646A1 Antimicrobial agent |
| 05/26/2004 | EP1389123A4 A non-lethal method for extracting crude hemocyanin from gastropod molluscs |
| 05/26/2004 | EP1313499A4 Method for treating the central nervous system by administration of igf structural analogs |
| 05/26/2004 | EP1251827B1 Nasally administrable antifungal cyclic peptide compositions |
| 05/26/2004 | EP1250148B1 Use of fsh for treating infertility |
| 05/26/2004 | EP1196443B1 Erythropoietin conjugates with polyethylenglycol |
| 05/26/2004 | EP1159296B1 METHOD FOR PRODUCING CYCLO-(Asp-DPhe-NMeVal-Arg-Gly) |
| 05/26/2004 | EP1150705B1 Protection of cells with bbi in connection with treatment with chemical agents |
| 05/26/2004 | EP1123110A4 Compositions and methods for promoting tissue repair using heat shock proteins |
| 05/26/2004 | EP1104475B1 C-myc is activated by beta-catenin and tcf-4 |
| 05/26/2004 | EP1083927B1 HUMAN MINOR VAULT PROTEIN p193 |
| 05/26/2004 | EP1059941B1 Pharmaceutical compositions and their use |
| 05/26/2004 | EP1056465A4 Antimicrobial peptides and derived metapeptides |
| 05/26/2004 | EP0971741B1 Use of avian antibodies |
| 05/26/2004 | EP0969851B1 Immunomodulatory complex and use thereof in helicobacter diseases |
| 05/26/2004 | EP0955058B1 Lactoferrin tablets |
| 05/26/2004 | EP0894129B1 Short external guide sequences |
| 05/26/2004 | EP0888125B1 GLYCOSYLATED IgG ANTIBODIES |
| 05/26/2004 | EP0863745B1 Thermosensitive biodegradable polymers based on poly(ether-ester) block copolymers |
| 05/26/2004 | EP0812331B1 Mhc-antigen complexes for detecting and purifying antigen-specific t cells |
| 05/26/2004 | EP0751781B1 Use of monoclonal antibodies or soluble oligomeric ligands in the manufacture of a medicament for the prevention or treatment of neoplastic disorders |
| 05/26/2004 | EP0729360B1 Linear and cyclic peptides for treatment or prevention of crohn's disease and/or ulcerative colitis |
| 05/26/2004 | CN1500096A Osteoprotegerin in milk |
| 05/26/2004 | CN1500095A Polymer conjugates of neublastin and methods of using ssame |
| 05/26/2004 | CN1500085A Lipid lowering biphenylcarboxamides |
| 05/26/2004 | CN1499982A Use of Il-18 inhibitors for treatment and/or prevention of heart disease |
| 05/26/2004 | CN1499981A Combined use of factor VII polypeptides and factor IX polypeptides |
| 05/26/2004 | CN1499980A Agents promoting proliferation and/or differentiation of hematopoietic stem cells and/or hematopoietic precursor cells |
| 05/26/2004 | CN1499979A Compsns. contg active fraction isolates from hedyotis diffusae and methods of use |
| 05/26/2004 | CN1499978A Manufacture of hemoglobin-based oxygen carrier |
| 05/26/2004 | CN1499927A Erythropoietin ameliorates chemotheapy-induced toxicity in vivo |
| 05/26/2004 | CN1498968A Constructing targeted carrier used in gene therapy for cancer and usage |
| 05/26/2004 | CN1498965A Method for preparing elspar modilfied by carbowax |
| 05/26/2004 | CN1498902A Immune suppression fusion protein, its coded nucleic acid and application |
| 05/26/2004 | CN1498899A Vegetable protein as well as preparation method and application |
| 05/26/2004 | CN1498898A Minor peptide of growth factor receptor KDR of specific combined blood vessel endothelium |
| 05/26/2004 | CN1498659A Nutritious supplementing agent contg. a-glucosidase inhibitor and a-amylase inhibitor |
| 05/26/2004 | CN1498657A Immunity growth substance for animal and its prepn. method |
| 05/26/2004 | CN1498656A Method and compsn. of nervous regulation protein for treating myocardial infarction |
| 05/26/2004 | CN1151268C Method for producing neurotrophon-3(NT-3) by using methanol yeast (pichia pastoris) and its application |
| 05/26/2004 | CN1151267C Method for producing human brain-derived neurotrophic factor NDNF by using methanol yeast (pichia pastoris) and its application |
| 05/26/2004 | CN1151258C Prodn. of erythropoietin by endogenous gene activation |
| 05/26/2004 | CN1151254C Structure and purification of venin-class thrombase for preventing and curing thrombotic diseases |
| 05/26/2004 | CN1151251C New human-phosphoguanosine reductase, its coding sequence and application |
| 05/26/2004 | CN1151196C Biologic medical equipment with antimicrobe coating |
| 05/26/2004 | CN1151172C Novel membrane proteine P76 of helicobacter pylori |
| 05/26/2004 | CN1151170C Isolated peptides derived from MAGE tumor rejection antigen precursops which complex with HLA-A2 molecules |
| 05/26/2004 | CN1150944C Application of alkaline fibroblast growth factor in preparing medicine to prevent and cure cerebral injury |